CCP
BSX icon

Carmel Capital Partners’s Boston Scientific BSX Stock Holding History

Carmel Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,294
Closed -$68.3K – 218
2023
Q3 		$68.3K Buy
1,294
+1,239
+2,253% +$65K 0.03% 222
2023
Q2 		$2.98K Hold
55
– – ﹤0.01% 342
2023
Q1 		$2.75K Buy
+55
New +$2.59K ﹤0.01% 394

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carmel Capital Partners's BSX Position: Q4 2023 in Review

Carmel Capital Partners sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 1,294 shares — an estimated $68.3K sold.

Carmel Capital Partners first reported a position in BSX in Q1 2023 and held it in 3 quarters. The position peaked at $68.3K in Q3 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Carmel Capital Partners reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
  • Carmel Capital Partners sold 1,294 Boston Scientific shares in Q4 2023, an estimated $68.3K.
  • Carmel Capital Partners first reported a position in Boston Scientific in Q1 2023 and held it in 3 quarters.
  • Carmel Capital Partners's Boston Scientific position peaked at $68.3K in Q3 2023.
  • 1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.